Oncobit AG
Medical Equipment Manufacturing
Schlieren, Zürich, Ch
15 employees
- Employees
- 15
- Contacts
- 2
- Emails
- 2
- Phones
- 1
Oncobit AG Overview
- Headquarters
- Schlieren, Zürich, Ch
- Website
- oncobit.com
- Industry
- Medical Equipment Manufacturing
- Employees
- 15
- Founded
- 2018
- Funding
- 1.7M
- Company Email
- Available in AeroLeads
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies Manufacturing
About Oncobit AG
Oncobit is a medtech UZH Spin-off, enabling personalized cancer care by matching patients to the best cancer treatment available. We are developing cancer-specific genomic fingerprinting and personalized monitoring tests and provide therapy decision support.
Oncobit AG Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Oncobit AG Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Sandra Nicole Freiberger | Head of Clinical Operations | Zurich, Switzerland |
Email
|
| Elena Clementi | Phd Cancer Biology, University of Zurich | Zurich, Switzerland |
View
|
| Bram Goorden | CEO - Non-executive Board Director | Geneva Metropolitan Area, Switzerland |
Email
Phone
|
| Daniel Schoener, Phd | Diagnostics Guru - Cleantech Enthusiast | United States |
View
|
Employees by Management Level
Individual contributor
5 profiles
Executive
2 profiles
VP / Head
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 2 | 2 | 0 |
| Executive | 1 | 1 | 0 |
| Healthcare | 1 | 1 | 0 |
Oncobit AG Tech Stack
Data / AI
2 profiles
Compare Similar Companies to Oncobit AG
IXICO
Biotechnology Research
InSphero
Biotechnology Research
Zetta Genomics Ltd
Biotechnology Research
Scailyte
Biotechnology
b-rayZ
Medical Device
Virdis Group
Staffing And Recruiting
UNOMR
Biotechnology Research
Altevax Biotech
Pharmaceutical Manufacturing
dEEGtal
Medical Equipment Manufacturing
ATLyphe AG
Biotechnology Research